Subject: Repligen Stock Rises Again
Date: Published: 10/29/91 (46 lines)
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

    OTC Focus:
    Stocks Rise, Breaking Three-Day Streak
    Of Losses, but Trading Volume Thins
    ----
    By Dave Pettit
    Staff Reporter of The Wall Street Journal

    NEW YORK -- Over-the-counter stocks snapped their
 three-day losing streak, but volume thinned from its recent
 levels.

[68 lines irrelevant to AIDS removed.  --sysop]

    Repligen gained 1 1/4 to 19 3/4.  Shearson Lehman Brothers
 analyst Teena Lehner upgraded her rating on the stock to
 "outperform" from "neutral," Dow Jones Professional Investor
 Report said.  The analyst said the recent sell-off in the
 stock was overdone.  Repligen fell sharply last week on news
 that Merck & Co. won't pursue development of Repligen's
 monoclonal antibodies as AIDS anti-infectives.  Merck and
 Repligen, though, will still jointly pursue an AIDS vaccine.
    U. S. Homecare jumped 1/2 to 18 1/4.  The company posted
 third-quarter net income of 17 cents a share, compared with
 yearago net of 11 cents a share.  Revenue rose to $13.3
 million from $8.4 million.
    Bytex lost 3/4 to 9 3/4.  A group including FMR Corp. said
 it cut its stake in the company to 6.57%.  In a Securities and
 Exchange Commission filing, the group said it sold 200,000
 shares on Oct. 17 for $10.79 a share.  It still holds 402,300
 Bytex shares.
    Escalade climbed 1 to 4.  The company had third-quarter net
 of 22 cents a share, reversing a year-ago loss of 38 cents a
 share.  Escalade cited increased sporting-goods sales and a
 reduction in the operating loss of its Marcy Fitness Products
 unit.
    U. S. Healthcare rose 3/4 to 31 1/4.  The operator of health
 maintenance organizations increased the quarterly dividend on
 its common stock to 11 cents from 8.34 cents.

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]